By Karl Hofmann, president & CEO, PSI Global health events of 2014 — particularly the Ebola epidemic in West Africa — seemed to shock many in the mainstream media, but no one working in development is surprised when health systems in weak states show their limitation. Looking back in order to look forward is aRead More ›
It might be the day after thanksgiving, but we’d still like to say we’re thankful for all the journalists and media outlets covering global issues, aiming to reveal the commonalities between humans in wildly disparate contexts. As you’re waiting in the checkout line on Black Friday, here are just a few of our go-to sources for theRead More ›
Can international NGOs be part of a “local solution”? Over on Devex, PSI President and CEO Karl Hofmann makes a resounding case for why they can, listing four ways international organizations can strengthen development locally: 1. Incentivize national staff. Procurement rules often dictate that national employees of international NGOs, or those working in their country ofRead More ›
Q&A with Klaus Brill, Head of Corporate Commercial Relations, Bayer.
Impact: How does Bayer determine a best investment in terms of value, business plan, audience and opportunity?
Read More ›
Klaus Brill (KB): At Bayer, we look for win-win investment opportunities coming to us through various organizations, governments or internal parties. For Bayer, we make sure that the opportunity matches our general interests in terms of our motto “Science for a Better Life.” We do an assessment to ensure that the opportunity matches one of our global core businesses: women’s health care, primary care, oncology, cardiology, and ophthalmology. If we can identify an interest from a business perspective, we can see the opportunity as a win-win investment for us and our partner.
Dr. Zulfiqar Bhutta shares his reflections on polio’s complex 2013. Dr. Bhutta is Founding Director of the Center of Excellence in Women and Child Health at Aga Khan University in Pakistan, and Co-Director of Research in Global Child Health at Toronto’s Hospital for Sick Children.Read More ›
It is imperative that both the public and private sectors work together. Businesses have invested in GAVI because they know that one of the strongest ways to promote global health is through immunization. And quite simply, vaccines provide a strong return on investment. Through collaboration between the public and private sectors, GAVI has been able to raise additional funds and, most importantly, bring significant private-sector expertise, skills, advocacy and visibility to its workRead More ›
How social franchise networks strengthen health systems
Dr. Aye Aye owns a small, tin roof clinic nestled next to her home in Yangon, Myanmar. There she serves the poor of her community with integrated health services including family planning, tuberculosis screening and treatment, diarrhea treatment, and more. She was one of the first doctors to join the Sun Quality Health Network, PSI/Myanmar’s social franchise network.
Read More ›
Jocelyn Wyatt, co-lead and executive director at IDEO.org, speaks with Eliza Villarino, senior news producer at Devex, about her suggestion for donors: Insist on a series of ‘quick and dirty’ tests before writing million-dollar checks for initiatives to reduce poverty or improve global health.Read More ›
Taking an idea to market and, eventually, saving and improving the lives of people around the world is a lengthy process, and many potential innovations fail along the way. Although governments and industry players are seeking to reduce barriers, the process is arduous and requires strong partnerships and coordination at many levels.Read More ›
The latest edition of Impact magazine seeks to uncover global health’s best investments, identify global health trends, and discuss barriers and solutions to scaling up promising interventions. Read the interview below from the issue, find the rest of the articles from the magazine here, and continue the conversation on Twitter using#BestBuys4GH.
Impact: GiveWell is known for using the very clear and direct framework of ‘proven/cost-effective/scalable’ when evaluating charities for public health. With your initiative, GiveWell Labs, you’re moving into new territory with the evaluation of areas outside public health and less straightforward frameworks. What was the impetus for this change and what challenges are you experiencing?
GiveWell: When GiveWell started, its co-founders had no experience in the non-profit sector, so they decided to focus on programs whose impact is easiest to measure: interventions with strong formal evidence of effectiveness from high-quality studies, such as randomized controlled trials. Now that we’ve been using this approach for a long time, we’re eager to learn about opportunities that might have great impact even if they are harder to measure, which is what GiveWell Labs is designed to do.Read More ›